Market Research Report
Histology and Cytology Market, By Examination Type, By Product, By Test Type, By End Use, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026
|Published by||AnalystView Market Insights||Product code||937182|
|Published||Content info||216 Pages
Delivery time: 2-3 business days
|Histology and Cytology Market, By Examination Type, By Product, By Test Type, By End Use, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026|
|Published: April 1, 2020||Content info: 216 Pages||
Histology and cytology market was valued at USD 12.3 billion by 2019, growing with 10.8% CAGR during the forecast period, 2020-2026
Histology and cytology can be defined as the scientific term that is used to study the tissue and cellular architecture of animals and plants. Histology refers to the study of function, composition, and structure of the tissue system, whereas cytology is referred to as the study of chemistry, function, and structure of the cell.
In Cytology, the cell is examined under the microscope after collecting it from the surface of the lesion. Both histology and cytology process is used during research study and diagnostic procedure. With the help of histology and cytology, the diagnosis of various cell-based and infectious diseases is examined such as smallpox, autoimmune diseases, inflammatory diseases, cancer, cervical diseases, and others. The advancement in the histology and cytology is also used during the study of enzymes, ligand-protein interaction, drug designing, research study, and many other methodologies and medical conditions.
Rapid advancements in immunohistochemistry and microscopy, rising standardization of path labs, and the growing prevalence of cancer are the major factors driving the growth of the global histology and cytology market. One of the most common causes of mortality all over the globe is cancer, which has resulted in the largest mortality rate in the world. Thus, the rising incidence of cancer patients is directly impacting the growing demand for the global market. According to the World Health Organization (WHO), the cancer burden has raised to 18.1 million in 2018 globally and this number is estimated to increase up to 43.8 million by 2025. In addition, splurging demand for in-vitro diagnostics is anticipated to boost the demand for histology among the laboratory professionals.
Moreover, digital pathology is gaining colossal importance as efficient management, interpretation, and acquisition of pathology information becomes crucial for disease diagnosis. The professionals are employing digital slides for histology training as these slides allow annotation of desired regions, which is likely to create lucrative opportunities for market growth. Furthermore, the global industry is also witnessing a huge growth concerning the healthcare industries. However, high costs associated with histology tests is predicted to hinder the market growth in the coming future.
Examination Type Takeaway
Based on the examination type, the worldwide industry is categorized into cytology and histology. The cytology segment is further sub-categorized into cervical cancer, and breast cancer. Of all these examination types, the cytology segment is anticipated to hold the largest market share in terms of revenue during the forecast period. This is mainly owing to the growing significance of early diagnosis and the patient's preference for cytology over histology type of examination. In addition, cytology involves detecting and diagnosing diseases with the help of a microscopic examination of small clusters and single cells in several types of smears. Thus, it is considered as the fastest, simplest, and safest means of diagnosing diseases. Furthermore, the specimens are easily available in the cytology tests and they also cause less discomfort with minimum critical complications.
On the other hand, the histology category is anticipated to grow exponentially during the projected timeframe owing to the growing incidence of cancer all over the globe. The histology examination is considered as the best source of diagnostic evaluation to improve the survival rate for cancer prognosis.
Based on the product, the global industry is bifurcated into consumables & reagents and instruments & analysis software systems. The consumable and reagents segment accounted for the largest market share in 2019 and is estimated to grow impressively during the forecast period. This is mainly owing to the large scale adoption of consumable and regents across different protocols from tissue engineering to treatment or processing. Moreover, the major market players of the industry are expanding their portfolio to histology consumables, which is helping in contributing most of the revenue share to the global market. For instance, Leica Biosystems offers a wide range of histology consumables including stains, cassettes, blades, cover glass, slides, autopsy consumables, mounting media, reagents, dissection consumables, and adhesives.
Test Type Takeaway
Base on the test type, the worldwide histology and cytology market is categorized into molecular genetics tests, flow cytometry, and microscopy tests. The microscopy tests market is estimated to register the largest market share owing to a rise in demand for research and development for early identification or detection and diagnosis of the disease. In addition, technological advancement in the treatment and diagnostic processes of infectious diseases and developments in molecular techniques is expected to propel the segmental market growth during the forecast period. Moreover, the molecular genetics tests are estimated to grow at an impressive rate by 2026.
On the basis of end-users, the global industry is categorized into clinical diagnostics, academic institutes, hospitals, and life sciences. The life sciences segment held the highest market share in 2019. The growth is attributed to the rising employment of digital cytology and histology instruments across toxicology and oncology studies. For healthcare manufacturers, pathology studies are essential for drug development is engaged in clinical trials and basic research.
In addition, emerging digital solutions related to cytology and histology are gaining significant traction across pharmaceutical and biotechnology companies. On the other hand, the hospital segment is anticipated to be the second-largest market owing to improved medical facilities and infrastructure.
Depending on geography, the global histology and cytology industry is divided into Europe, North America, Latin America, Asia Pacific, and Middle East & Africa. The North America region is expected to subjugate the market in the projected timeframe owing to the availability of sophisticated healthcare infrastructure, government policies for reimbursement, and growing awareness regarding cancer and regular health screening. According to the World Health Organization (WHO), the U.S. exhibits a large pool of geriatric population and patients suffering from cancer due to unhealthy habits.
Furthermore, the presence of leading manufacturers and product approvals are likely to propel the regional market growth during the forecast period. Along with North America, the Asia Pacific market for histology and cytology is predicted to be the fastest-growing owing to the large elderly population, socioeconomic conditions, and unhealthy lifestyle.
Key Vendor Takeaway
Some of the key players of the global histology and cytology industry include Hologic, Inc,.,Abbott,, Hoffmann-La Roche Ltd., Becton, Dickinson & Company, Danaher, Meck KGaA, Thermofisher Scientific, Inc., Sysmex Corporation, Trivitron Healthcare, and Koninklijke Philips N.V.
These players are focusing more on R&D activities, product developments, acquisitions, and geographical expansion to maintain a strong position in the market. For instance, in April 2019, a CE IVD mark was received by Hologic, Inc. for its cytology slide processor, ThinPrep Genesis. The company aims to strengthen its market position in the region of Europe.
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year - 2015 to 2018
Base Year - 2019
Estimated Year - 2020
Projected Year - 2026
Traders, Distributors, and Suppliers
Government and Regional Agencies
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
HISTOLOGY AND CYTOLOGY MARKET KEY PLAYERS
Patterson Medical Holdings, Inc.
Concentra Operating Corporation
Kindred Healthcare, Inc.
EMS Physio Ltd.
US Physical Therapy, Inc.
HISTOLOGY AND CYTOLOGY MARKET, BY EXAMINATION TYPE
HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT
Consumable and Reagents
Instruments and Analysis Software System
HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE
Molecular Genetics Test
HISTOLOGY AND CYTOLOGY MARKET, BY END USE
HISTOLOGY AND CYTOLOGY MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of LATAM
Middle East and Africa
United Arab Emirates
Rest of MEA